Does health technology assessment compromise access to pharmaceuticals?
Year of publication: |
2023
|
---|---|
Authors: | Büssgen, Melanie ; Stargardt, Tom |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 24.2023, 3, p. 437-451
|
Subject: | AMNOG | Health policy | HTA | Launch delay | Pharmaceuticals | Price regulation | Arzneimittel | Gesundheitspolitik | Pharmaindustrie | Pharmaceutical industry | Preisregulierung | Arzneimittelmarkt | Pharmaceutical market | Technikfolgenabschätzung | Technology assessment | Pharmakologie | Pharmacology | Gesundheitskosten | Health care costs |
-
Does health technology assessment compromise access to pharmaceuticals?
Büssgen, Melanie, (2023)
-
The politics of the international pricing of prescription drugs
Harrison, Christopher Scott, (2004)
-
Byrski, Dennis, (2021)
- More ...
-
Büssgen, Melanie, (2024)
-
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany : a comment
Gandjour, Afschin, (2023)
-
Does health technology assessment compromise access to pharmaceuticals?
Büssgen, Melanie, (2023)
- More ...